The mystique of hepatic tolerogenicity

Seminars in Liver Disease

Volumn 20, Issue 4, 2000, Pages 497-510

  Starzl, T E ^a   Murase, N ^a   Demetris, A ^a   Trucco, M ^a   Fung, J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Clonal exhaustion deletion; Immune indifference; Immunologic tolerance; Liver allograft; Liver tolerogenicity; Liver transplantation; Organ allograft

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOBLAST ANTIBODY; PREDNISONE; TACROLIMUS;

ALLOGRAFT; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; GRAFT FAILURE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CHIMERA; CLONE CELLS; HUMANS; IMMUNE TOLERANCE; LEUKOCYTES; LIVER TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034517874     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13158     Document Type: Article

References (140)

1. Historical landmarks in clinical transplantation: Conclusions from the consensus conference held at the University of California, Los Angeles (UCLA)
2. History of clinical transplantation
3. The reversal of rejection in human renal hemografts with subsequent development of homograft tolerance
4. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction
5. Successful homotransplantation of the kidney between non-identical twins
6. Study of transplantation immunity after total body irradiation: Clinical and experimental investigation
7. Renal homotransplantation in man after radiation of the recipient
8. Homologous human kidney transplantation. Experience with six patients
9. A functioning kidney homotransplant in the dog
10. Prolonged survival of human-kidney homografts by immuno-suppressive drug therapy
11. Evaluation of long-functioning human kidney transplants
12. Inhibition of the rejection of renal homografts in dogs by purine analogues
13. A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs
14. Prope tolerance, perioperarive Campath IH, and low-dose cyclosporin monotherapy in renal allograft recipients
15. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients
16. The lost chord: Microchimerism
17. Homotransplantation of the liver in humans
18. Orthotopic homotransplantation of the human liver
19. The clinical use of antilymphocyte globulin in renal homotransplantation
20. Homotransplantation of multiple visceral organs
21. Rejection of the multivisceral allografts in rats: A sequential analysis with comparison to isolated orthotopic small bowel and liver grafts
22. Long survival in rats after multivisceral versus isolated small bowel allotransplantation under FK 506
23. Factors determining short- and long-term survival after orthotopic liver homotransplantation in the dog
24. Efforts to mitigate or prevent rejection
25. La greffe de foie orthotopique chez le porc
26. Orthotopic homotransplantation of the liver in the pig
27. Observations of orthotopic liver transplantation in the pig
28. Prolonged survival of liver transplants in the pig
29. Rejection in Unmodified Animals
30. Pathology of liver transplantation in the pig
31. Pathology of the orthotopic homograft and heterograft
32. "Actively acquired tolerance" of foreign cells
33. Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance
34. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow
35. Haematopoietic chimera in man after allogenic (homologous) bone-marrow transplantation
36. Immunological reconstitution of sex-linked lymphopenic immunological deficiency
37. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome
38. Allogeneic marrow grafting: A story of man and dog
39. Induction of immunological tolerance by porcine liver allografts
40. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens
41. Reversal of transplantation immunity by liver grafting
42. Orthotopic liver allografts in the rat
43. Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rat
44. Value of a physiological liver transplant model in rats. Induction of specific graft tolerance in a fully allogeneic strain combination
45. FK 506 suppression of heart and liver allograft rejection II: The induction of graft acceptance in rat
46. Variable chimerism, graft versus host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown-Norway rats
47. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues
48. Murine liver allograft transplantation: Tolerance and donor cell chimerism
49. Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-I collagen
50. Split tolerance induced by orthotopic liver transplantation in mice
51. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor
52. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival
53. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction
54. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo
55. Mechanisms of donor-specific unresponsiveness induced by liver grafting
56. Strange brew: T cells in the liver
57. Class I transplantation antigens in solution in body fluids and in the urine
58. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody
59. Soluble HLA antigens in the circulation of liver graft recipients
60. Organ graft tolerance: The liver effect
61. Tolerance of porcine renal allografts induced by donor spleen cells and seven days' treatment with cyclosporine
62. Presensitization by skin grafting from MHC class I or class II deficient mice identifies class I antigens as inducers of allosensitization
63. Primary vascularized allografts of hearts in mice. The role of H-2D, H-2K and non-H-2 antigens in rejection
64. Kidney transplants in mice: An analysis of the immune status of mice bearing long-term H-2 incompatible transplants
65. Drug induced immunologic tolerance
66. On the acquisition of tolerance by adult cells
67. Development aspects of immunity
68. The mechanism of immunological paralysis
69. Host Graft Adaptation
70. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
71. Weaning of immuno-suppression in long term liver transplant recipients
72. Weaning of immuno-suppression in liver transplant recipients
73. Efforts to mitigate or prevent rejection
74. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution
75. Immunization with skin isografts taken from tolerant mice
76. Pathogenesis of a local graft versus host reaction: Immunogenicity of circulating host leukocytes
77. Activation of transplant immunity: Effect of donor leukocytes on thyroid allograft rejection
78. Immunobiology of tissue transplantation: A return to the passenger leukocyte concept
79. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor-strain dendritic cells
80. Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver
81. Replacement of donor lymphoid tissue in human small bowel transplants under FK 506 immunosuppression
82. Cell migration, chimerism, and graft acceptance
83. Systemic chimerism in human female recipients of male livers
84. Chimerism after liver transplantation for type IV glycogen storage disease and Type I Gaucher's disease
85. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation
86. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
87. Tolerance, danger, and the extended family
88. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
89. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
90. T cell priming versus T cell tolerance induced by synthetic peptides
91. Biology of lymphocytic choriomeningitis infection: Virus induced immune disease
92. Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells
93. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb
94. Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation: With particular reference to the liver
95. Presence of hematopoietic stem cells in the adult liver
96. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation
97. Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation
98. Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression
99. The dendritic cell system and its role in immunogenicity
100. Microchimerism, dendritic cell progenitors and transplantation tolerance
101. Fine quantitation by competitive PCR of circulating donor cells in post-transplanted chimeric recipients
102. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation
103. The heterogenous distribution of chimerism produced by rat organ and bone marrow allotransplantation
104. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection
105. Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts
106. Transplantation milestones: Viewed with one- and two-way paradigms of tolerance
107. Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients
108. Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis
109. Antigen localization and migration in immunity and tolerance
110. Explanation for loss of the HLA matching effect
111. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?
112. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "The dualistic effect."
113. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation
114. Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients
115. Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry (PCR-FLOW)
116. Immunology taught by viruses
117. Antigen localization regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity
118. On immunological memory
119. A biological role for the major histocompatibility antigens
120. The discovery of MHC restriction
121. Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity
122. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel route for initiation of rejection
123. Early events in liver allograft rejection: Delineation of sites simultaneous intragraft and recipient lymphoid tissue sensitization
124. Antiviral immunity
125. Mature lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigen environment
126. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
127. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
128. Chimerism and transplantation tolerance: Cause and effect
129. Lymphoid/non-lymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow
130. Ablation of "tolerance" and induction of diabetes by viruses infection in viral antigen transgenic mice
131. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-α
132. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat
133. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection
134. Infusion of donor leukocytes to induce tolerance in organ allograft recipients
135. Graft adaptation: Studies on possible mechanisms in long-term surviving rat renal allografts
136. Mouse liver transplantation tolerance: The role of hepatocytes and nonparenchymal cells
137. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats
138. Costimulation pathways in host immune responses to allogeneic hepatocytes
139. A functional model of hepatocyte transplantation for in vivo immunologic studies
140. In viva immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model